European Study Provides New Insight into Public Interest in Medicines Research
Clinical Conductor Adds Flexible CTMS Features to Facilitate Dynamic Research
PAREXEL Strengthens Commitment to Global Biopharmaceutical Workforce with New PAREXEL Academy Programs
The Lancet Psychiatry: Neuroscientists Call for Immediate Action to Determine the Dangers and Benefits of Cognitive-Enhancing Drug Use in Healthy People
TransCelerate BioPharma Launches Two New Global Initiatives That Aim to Improve Clinical Research
iCardiac Launches Industry-First Full Risk-Sharing Program for Cardiac Safety Studies
Sponsors Are Guaranteed to Receive Precise, Conclusive Thorough QT Results or Pay Nothing
TRI Announces OPRA – SaaS Risk-Based Monitoring (RBM) Platform
Certara Launches its Cardiac Safety Simulator V2.0
European Medicines Agency and Heads of Medicines Agencies Consult on Common Network Strategy to 2020
Clinical Ink Merges with Centroshealth and Completes Financing Led by MPM Capital
Using eSource Data In Pivotal Studies
Many years before the FDA offered its eSource Guidance in September 2013, Sirion Therapeutics launched its first two pivotal Phase III studies using entirely electronic source data collection.
ICON to Acquire MediMedia Pharma Solutions
Investigator Training Efficiencies Highlighted in New CTTI GCP Recommendations
TransCelerate BioPharma Welcomes Merck & Co. and Novo Nordisk to its Membership Roster
TransCelerate BioPharma announced two new members, Merck & Co. Inc., and Novo Nordisk.
New PwC Report- Regulatory Innovation Should Adapt to New Health Economy
Forty-three percent of pharma and life sciences execs now support FDA evaluating drugs based on both clinical and economic effectiveness
Conatus Pharmaceuticals Implements Veeva Vault eTMF and QualityDocs to Speed Global Clinical Trials of New Biologic, Emricasan
Bristol-Myers Squibb Commits to Global Impact Partnership and Site Advocacy Group
INC Research First CRO to Launch Site Advocacy Group to Enhance the Clinical Research Process
The Food and Drug Administration's Oversight of Clinical Trials